Quantcast

Latest Warfarin Stories

2014-07-30 23:01:48

The Firm is investigating Xarelto lawsuits on behalf of individuals who allegedly suffered uncontrollable bleeding, strokes, deep vein thrombosis, or pulmonary embolism due to the blood thinner. New York, New York (PRWEB) July 30, 2014 The family of a Vermont man who died from uncontrollable brain bleeding has filed a Xarelto lawsuit (http://www.xareltolawsuitcenter.com/ ) alleging his death was caused by the blood thinner, Bernstein Liebhard LLP reports. According to the complaint, which...

2014-07-23 16:26:55

British Medical Journal publishes biased article regarding PRADAXA RIDGEFIELD, Conn., July 23, 2014 /PRNewswire/ -- Boehringer Ingelheim (BI) wants to set the record straight following misleading statements that the British Medical Journal (BMJ) published today regarding Pradaxa® (dabigatran etexilate mesylate). We are concerned that this publication may alarm patients and prompt them to stop taking PRADAXA, thereby increasing their risk of stroke. To be clear, many of the allegations made...

2014-07-15 12:23:54

RnRMarketResearch.com adds "Rodenticides Market by Type (Anticoagulants, Non-Anticoagulants, and Others), by End User (Agricultural Field, Warehouses, Pest Control Companies, Urban Centers, and Others) & by Geography - Global Trends & Forecasts to 2019" to its store. DALLAS, July 15, 2014 /PRNewswire-iReach/ -- The rodenticides market size is projected to increase due to the demand for food grains and rising farmers concerns over food wastage due to rodents. Rodenticides are also used in...

2014-07-07 23:06:26

On July 1, the FDA published that 6 lots of Coumadin (Warfarin Sodium) for Injection, 5 mg single-use vials, by Bristol-Myers Squibb, are recalled due to the presence of visible particulate matter. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 07, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on...

2014-06-26 08:28:27

Idarucizumab being evaluated to specifically reverse the anticoagulant effect of PRADAXA RIDGEFIELD, Conn., June 26, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to idarucizumab*, an investigational fully humanized antibody fragment, or Fab, being studied as a specific antidote for Pradaxa (dabigatran etexilate mesylate). "Boehringer Ingelheim is pleased that the...

2014-06-25 23:11:26

Several Xarelto users are considering filing a Xarelto lawsuit after suffering dangerous side effects associated with the popular blood thinner drug Xarelto (rivaroxaban). The Levin, Papantonio law firm has launched a Xarelto lawsuit website to assist those who have been injured from severe internal bleeding experienced after taking the blood thinner drug. Pensacola, FL (PRWEB) June 25, 2014 Users of the prescription drug Xarelto (rivaroxaban) are beginning to file Xarelto lawsuits after...

2014-06-20 08:23:38

RIDGEFIELD, Conn., June 20, 2014 /PRNewswire/ -- Boehringer Ingelheim announced today the initiation of a new international study of Pradaxa® (dabigatran etexilate mesylate). The RE-CIRCUIT(TM) trial (Randomized Evaluation of dabigatran etexilate Compared to warfarIn in pulmonaRy vein ablation: assessment of different peri-proCedUral antIcoagulation sTrategies) will evaluate uninterrupted treatment with PRADAXA, compared to warfarin, in patients with paroxysmal or persistent non-valvular...

2014-06-11 08:32:01

LONDON, June 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Coagulation Diagnostic Testing Marketshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/coagulation_diagnostic_testing_markets_1.html Coagulation testing, which encompasses both laboratory and point of care (POC) testing, will continue to be one of the most important segments of the in vitro diagnostics market for the foreseeable future. Many of the new models of laboratory...

2014-06-10 12:29:47

Additional Novel Oral Anticoagulants are Expected to Gain Approval in China for AF and VTE in the Next Three to Four Years, According to Findings from Decision Resources Group BURLINGTON, Mass., June 10, 2014 /PRNewswire/ -- Decision Resources Group finds that the high cost of therapy remains a significant barrier for uptake of novel oral anticoagulants (NOACs) in the Chinese market. Warfarin, the mainstay of anticoagulation treatment, is listed in the national essential drugs list and is...

2014-05-29 23:15:58

Boehringer Ingelheim Agrees to Pay $650 Million To Settle 4,000 Pradaxa Lawsuit That Allege Internal Bleeding After Taking The Prescription Medication. Columbus, OH (PRWEB) May 29, 2014 Wright & Schulte LLC, an experienced personal injury law firm representing plaintiffs in Pradaxa lawsuits pending in federal court, reports that Boehringer Ingelheim has agreed to pay $650 million to settle Pradaxa lawsuits filed on behalf of plaintiffs who allegedly experienced serious internal...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related